BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 3488296)

  • 21. Complement levels in normal and inflamed aqueous humor.
    Mondino BJ; Rao H
    Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):380-4. PubMed ID: 6550582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Hugli TE
    Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
    [No Abstract]   [Full Text] [Related]  

  • 23. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
    Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
    Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
    Ohkohchi K; Takematsu H; Tagami H
    Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of exercise on complement activity.
    Smith JK; Chi DS; Krish G; Reynolds S; Cambron G
    Ann Allergy; 1990 Oct; 65(4):304-10. PubMed ID: 2221489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry and biology of anaphylatoxins.
    Hugli TE
    Complement; 1986; 3(3):111-27. PubMed ID: 3542363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on complement activation in cardiopulmonary bypass--experimental and clinical evaluations].
    Yamasaki M
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb; 37(2):234-41. PubMed ID: 2788676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S; Sakurabayashi I
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract]   [Full Text] [Related]  

  • 29. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
    Soejima K; Koyanagi H; Endo M; Hashimoto A; Imai Y
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb; 35(2):200-4. PubMed ID: 3495614
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J
    Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum complement levels and severity of sepsis.
    Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between complement activation and susceptibility to decompression sickness.
    Ward CA; McCullough D; Fraser WD
    J Appl Physiol (1985); 1987 Mar; 62(3):1160-6. PubMed ID: 3494726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyacrylonitrile complement activation attenuated by simultaneous ultrafiltration and adsorption.
    Röckel A; Hertel J; Perschel WT; Walb D; Fiegel P; Panitz N; Abdelhamid S
    Nephrol Dial Transplant; 1987; 2(4):251-3. PubMed ID: 3118267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.
    Ohkohchi K; Takematsu H; Tagami H
    J Invest Dermatol; 1986 Jul; 87(1):65-7. PubMed ID: 3487596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation produced by biomaterials.
    Chenoweth DE
    Artif Organs; 1988 Dec; 12(6):508-10. PubMed ID: 3265053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement-derived anaphylatoxins in human donor corneas treated with excimer laser.
    Gardner BP; Pleyer U; Mondino BJ; Sumner HL; Frieberg ML; Imperia PS
    Ophthalmic Surg Lasers; 1995; 26(6):568-71. PubMed ID: 8746579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement activation in systemic sclerosis.
    Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
    J Clin Lab Immunol; 1990 Jan; 31(1):39-41. PubMed ID: 1966983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.
    Wust SK; Blumenthal MN; Corazalla EO; Benson BA; Dalmasso AP
    Transl Res; 2006 Oct; 148(4):157-63. PubMed ID: 17002917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.